Mazzari, Mario Attilio
 Distribuzione geografica
Continente #
NA - Nord America 1.987
EU - Europa 1.806
AS - Asia 1.490
SA - Sud America 270
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 5.588
Nazione #
US - Stati Uniti d'America 1.941
DE - Germania 826
SG - Singapore 791
CN - Cina 365
SE - Svezia 279
BR - Brasile 233
UA - Ucraina 126
IT - Italia 115
FR - Francia 114
GB - Regno Unito 108
IE - Irlanda 85
ID - Indonesia 63
VN - Vietnam 62
IN - India 43
RU - Federazione Russa 41
FI - Finlandia 32
TR - Turchia 25
HK - Hong Kong 24
BD - Bangladesh 19
AR - Argentina 18
CA - Canada 18
MX - Messico 18
PL - Polonia 18
IQ - Iraq 17
JP - Giappone 17
NL - Olanda 16
AT - Austria 10
ES - Italia 10
UZ - Uzbekistan 10
ZA - Sudafrica 10
MA - Marocco 9
IR - Iran 8
JO - Giordania 7
BE - Belgio 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
EC - Ecuador 5
EU - Europa 5
KR - Corea 5
KG - Kirghizistan 4
SA - Arabia Saudita 4
CL - Cile 3
PE - Perù 3
PH - Filippine 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
VE - Venezuela 3
AL - Albania 2
AU - Australia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
IL - Israele 2
JM - Giamaica 2
NP - Nepal 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
HN - Honduras 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SN - Senegal 1
UY - Uruguay 1
Totale 5.588
Città #
Chandler 443
Singapore 399
Ashburn 141
New York 113
Dublin 85
Beijing 80
San Mateo 79
Jacksonville 74
Nürnberg 61
Jakarta 56
Wilmington 52
Nanjing 45
Los Angeles 43
Boston 40
Munich 35
Marseille 33
Hefei 32
Houston 32
Princeton 31
Lancaster 30
Moscow 30
Ann Arbor 29
Chicago 24
Dearborn 24
Ho Chi Minh City 24
Buffalo 23
Milan 22
Frankfurt am Main 20
Seattle 20
Woodbridge 20
Lawrence 18
São Paulo 17
Izmir 16
Norwalk 15
Nanchang 14
Rome 14
Hong Kong 13
Nuremberg 13
Tokyo 13
Hebei 12
University Park 12
Andover 11
Dallas 11
Kent 11
Fairfield 10
Redwood City 10
Shenyang 10
Hanoi 9
Kraków 9
Vienna 9
Washington 9
Zhengzhou 9
Baghdad 8
Helsinki 8
Johannesburg 8
Manchester 8
Montreal 8
Santa Clara 8
Tashkent 8
Amman 7
Bremen 7
Brooklyn 7
Detroit 7
Düsseldorf 7
San Francisco 7
Almere Stad 6
Bari 6
Berlin 6
Brussels 6
Cattolica 6
Chennai 6
Kish 6
Mountain View 6
Rio de Janeiro 6
Salvador 6
Stockholm 6
Tyler 6
Augusta 5
Bexley 5
Busto Arsizio 5
Changsha 5
Kunming 5
Leawood 5
London 5
Mexico City 5
Salé 5
Seoul 5
Shanghai 5
Tianjin 5
Warsaw 5
Atlanta 4
Birmingham 4
Bishkek 4
Biên Hòa 4
Campo Grande 4
Charlotte 4
Cincinnati 4
Denver 4
Hải Dương 4
Jiaxing 4
Totale 2.680
Nome #
Renal artery stenting in patients with chronic ischemic heart disease 223
The HEART study: a real-world experience using the CID Chrono Carbostent in primary and rescue PCI 222
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 208
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 205
Outcome of non-cardiac surgery after stent implantation in the DES era: results of the Surgery After Stent (SAS) registry 195
Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures 179
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 177
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry 176
Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach 174
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry 171
Selective Intracoronary injection of sestamibi to detect myocardial viability. Prediction of perfusion and contractile recovery after percutaneous transluminal coronary angioplasty 170
Coronary bifurcation lesions: to stent one branch or both? A meta-analysis of patients treated with drug eluting stents. 151
Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: A prospective study 148
Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study 146
Influence of the amount of myocardium subtended by a stenosis on fractional flow reserve 140
Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents. 134
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 131
Anomalous origin of coronary arteries from the "wrong" sinus in athletes: Diagnosis and management strategies. 129
Transradial approach (left vs right) and procedural times during percutaneous coronary procedures: TALENT study 117
Impact of the COVID-19 Pandemic on Enhanced Recovery After Surgery (ERAS) Application and Outcomes: Analysis in the “Lazio Network” Database 116
Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: a prospective study 111
Post-procedural renal microvascular perfusion measured using the Quantitative Blush Evaluator (QuBE) predicts improvement in renal function in patients undergoing percutaneous renal artery stenting 103
Outcome of non-cardiac surgery after stent implantation in the DES era: results of the Surgery After Stent (SAS) registry 103
Provisional TAP-stenting strategy to treat bifurcated lesions with drug-eluting stents: one-year clinical results of a prospective registry. 92
Restructuring surgical training after COVID-19 pandemic: A nationwide survey on the Italian scenario on behalf of the Italian polyspecialistic young surgeons society (SPIGC) 88
Comparative assessment of mammalian target of rapamycin inhibitor-eluting stents in the treatment of coronary artery bifurcation lesions: the CASTOR-Bifurcation registry. 88
A pilot study with a new, rapid-exchange, thrombus-aspirating device in patients with thrombus-containing lesions: the Diver C.E. study. 82
Evaluation of a strategy for treating bifurcated lesions by single or double stenting based on the Medina classification. 80
Transradial approach (left vs right) and procedural times during percutaneous coronary procedures: TALENT study. 79
Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study 78
Use of a second, "buddy" wire during percutaneous coronary interventions: A simple solution for some challenging situations 76
Percutaneous treatment of a large coronary aneurysm using the self-expandable symbiot PTFE-covered stent 76
Adjunctive devices in primary or rescue PCI: A meta-analysis of randomized trials 75
Catheter-induced straightening of external iliac tortuosity: A cause of pseudostenosis to be borne in mind 74
Use of a novel high-osmolar gadolinium chelate, gadobutrol, for percutaneous renal artery stenting in two patients with chronic renal failure 74
"Fogarty-like" removal of large coronary thrombus. 73
Directional atherectomy before stenting versus stenting alone in percutaneous coronary interventions: A meta-analysis. 72
Endothelin-1 and acute myocardial infarction: A no-reflow mediator after successful percutaneous myocardial revascularization 70
Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: The 'OPTIMIZE-IT' pilot randomized study 68
Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: The BINARIO (BIcarbonato e N-Acetil-cisteina nell'infaRto mIocardico acutO) study 68
Outcome of patients treated by a novel thin-strut cobalt-chromium stent in the drug-eluting stent era: Results of the SKICE (Skylor in real world practice) registry. 67
Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction 64
Urgent PCI in patients with stent thrombosis: an observational single-center study comparing thrombus aspiration and standard PCI 61
Comparison of the transradial and transfemoral approaches for coronary angiographic evaluation in patients with internal mammary artery grafts 56
Outcomes of the tacrolimus drug-eluting Janus stent: A prospective two-centre registry in high-risk patients 54
Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI 52
Rescue percutaneous coronary intervention for failed thrombolysis in a patient with anomalous coronary arteries 49
Combined percutaneous pulmonary valvuloplasty and patent foramen ovale closure in an adult with recurrent transient ischemic attacks 49
Selective intracoronary injection of sestamibi to detect myocardial viability: Perdiction of perfusion and contractile recovery after percutaneous transluminal coronary angioplasty 47
Comparison of outcomes (early and six-month) of direct stenting with conventional stenting (a meta-analysis of ten randomized trials). 47
The complex link between oxidised low-density lipoprotein and unstable angina 46
Manual thrombus-aspiration improves myocardial reperfusion: The randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial 40
Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison 37
Angiographics evalutation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI 35
Endotelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization 24
Totale 5.670
Categoria #
all - tutte 24.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.813


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021204 0 0 0 0 0 25 47 20 59 3 39 11
2021/2022419 22 30 3 15 39 8 9 90 20 29 57 97
2022/20231.042 135 149 107 152 49 138 40 88 133 13 17 21
2023/2024530 21 132 16 12 20 145 15 4 14 21 69 61
2024/2025802 20 35 69 28 79 26 12 44 122 55 192 120
2025/20261.323 401 56 135 255 443 33 0 0 0 0 0 0
Totale 5.670